Drugs / Mucofalk
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01882088 | Apr 2012 → Sep 2016 | gastroesophageal reflux disease | Russian Academy of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mucofalk | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01882088 ↗ |
| Route | Oral | “Recommended dosage and administration: orally” NCT01882088 ↗ |